NPPA has put a cap on Trade Margin of 42 select non-scheduled anti-cancer medicines under ‘Trade Margin Rationalization (TMR)’ Approach resulting in reduction up to 90% of Maximum Retail Price (MRP) of 526 brands of these medicines.https://t.co/iZDoueahS1— PIB India (@PIB_India) August 10, 2021
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


